Kivo Health vs Noom
Side-by-side comparison of AI visibility scores, market position, and capabilities
Durham NC YC W23 Medicare-covered at-home pulmonary rehab for 16M US COPD patients shipping Kivo Kit; $475K MassMutual/Samsung NEXT-backed competing with Propeller Health for virtual respiratory rehabilitation at the 3-5% treatment gap.
About
Kivo Health is a Durham, North Carolina-based telehealth company — backed by Y Combinator (W23) with $475,000 raised from MassMutual Ventures, Samsung NEXT Ventures, Heuristic Capital, Quint Ventures, and SNR Ventures — providing Medicare-covered 8-week pulmonary rehabilitation programs to patients with chronic obstructive pulmonary disease (COPD), asthma, bronchitis, and other chronic lung conditions through an at-home telehealth delivery model that ships comprehensive Kivo Kits (containing an iPad pre-loaded with the Kivo platform and monitoring equipment) directly to patients' homes for virtual respiratory therapist sessions, structured exercise programs, and lung function monitoring. Founded in 2021 by founders with medical backgrounds and targeting the 16 million US patients with chronic lung conditions who represent $50 billion in annual healthcare spending.
Noom is a digital weight health program combining psychology-based behavioral coaching, food logging, and human coaching to help members build sustainable healthy habits.
About
Noom is a digital health company founded in 2008 that has grown into one of the most widely used weight management platforms, serving millions of members through its psychology-driven approach to behavior change. The platform combines daily lessons on cognitive behavioral techniques, food logging with a traffic-light color-coding system, personal coaching from trained health coaches, and group support to help members change their relationship with food and exercise. Noom raised over $540M and reached a $3.7B valuation, establishing it as a leading consumer digital health company. The company has expanded beyond weight loss into a broader weight health platform addressing both weight management and weight-related conditions including type 2 diabetes management with its Noom Med offering that includes GLP-1 medication prescribing. As GLP-1 medications like Ozempic and Wegovy have transformed the weight loss market, Noom has positioned its behavioral coaching as essential to sustainable results alongside medication. The platform serves both direct-to-consumer subscribers and employer health plans that offer Noom as a weight management benefit for their workforces.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.